- Home
- EDTK vs CTXR Comparison
EDTK vs CTXR Comparison
Compare EDTK & CTXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDTK
- CTXR
- Stock Information
- Founded
- EDTK 2013
- CTXR 2007
- Country
- EDTK China
- CTXR United States
- Employees
- EDTK N/A
- CTXR N/A
- Industry
- EDTK Other Consumer Services
- CTXR Biotechnology: Pharmaceutical Preparations
- Sector
- EDTK Real Estate
- CTXR Health Care
- Exchange
- EDTK Nasdaq
- CTXR Nasdaq
- Market Cap
- EDTK 14.7M
- CTXR 14.6M
- IPO Year
- EDTK 2020
- CTXR N/A
- Fundamental
- Price
- EDTK $0.88
- CTXR $1.53
- Analyst Decision
- EDTK
- CTXR Strong Buy
- Analyst Count
- EDTK 0
- CTXR 3
- Target Price
- EDTK N/A
- CTXR $53.00
- AVG Volume (30 Days)
- EDTK 6.5K
- CTXR 6.7M
- Earning Date
- EDTK 08-18-2025
- CTXR 08-11-2025
- Dividend Yield
- EDTK N/A
- CTXR N/A
- EPS Growth
- EDTK N/A
- CTXR N/A
- EPS
- EDTK N/A
- CTXR N/A
- Revenue
- EDTK $624,365.00
- CTXR N/A
- Revenue This Year
- EDTK N/A
- CTXR N/A
- Revenue Next Year
- EDTK N/A
- CTXR N/A
- P/E Ratio
- EDTK N/A
- CTXR N/A
- Revenue Growth
- EDTK N/A
- CTXR N/A
- 52 Week Low
- EDTK $0.80
- CTXR $0.65
- 52 Week High
- EDTK $1.27
- CTXR $26.25
- Technical
- Relative Strength Index (RSI)
- EDTK 43.35
- CTXR 68.44
- Support Level
- EDTK $0.85
- CTXR $0.76
- Resistance Level
- EDTK $0.95
- CTXR $1.45
- Average True Range (ATR)
- EDTK 0.06
- CTXR 0.31
- MACD
- EDTK -0.00
- CTXR 0.06
- Stochastic Oscillator
- EDTK 22.28
- CTXR 47.63
About EDTK Skillful Craftsman Education Technology Limited
Skillful Craftsman Education Technology Ltd provides online education and technology services in China. The services comprises of two aspects - Online vocational training and Virtual simulation experimental training. It covers a wide range of subjects, including mechanics, electronics, auto repair and construction. Majority of its revenues are generated from the People's Republic of China.
About CTXR Citius Pharmaceuticals Inc.
Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. The company is currently advancing four proprietary product candidates namely, LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma. Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections, Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries, Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids, and others.